Login / Signup

Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence.

Mirko GrieselTobias P SeraphinNikolaus Christian Simon MezgerLucia HämmerlJana FeuchtnerWalburga Yvonne Joko-FruMazvita Sengayi-MuchengetiBiying LiuSamukeliso VumaAnne KorirGladys C ChesumbaiSarah NamboozeCesaltina F LorenzoniMarie-Thérèse Akele-AkpoAmalado AyemouCheick B TraoréTigeneh WondemagegnehuAndreas WienkeChristoph ThomssenDonald Maxwell ParkinAhmedin JemalEva Johanna Kantelhardt
Published in: The oncologist (2021)
Despite evidence-based interventions including guideline-adherent treatment for cervical cancer (CC), there is huge disparity in survival across the globe. This comprehensive multinational population-based registry study aimed to assess the status quo of presentation, treatment guideline adherence, and survival in eight countries. Patients across sub-Saharan Africa present in late stages, and treatment guideline adherence is remarkably low. Both factors were associated with unfavorable survival. This report warns about the inability of most women with cervical cancer in sub-Saharan Africa to access timely and high-quality diagnostic and treatment services, serving as guidance to institutions and policy makers. With regard to clinical practice, there might be cancer-directed treatment options that, although not fully guideline adherent, have relevant survival benefit. Others should perhaps not be chosen even under resource-constrained circumstances.
Keyphrases